Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood

Detalles Bibliográficos
Autores principales: Xu, Xiaoqian, Yang, Jun, Cai, Yu, Li, Su, Niu, Jiahua, Zhou, Kun, Jiang, Ying, Xu, Xiaowei, Shen, Chang, Huang, Chongmei, Qiu, Huiying, Wei, Daolin, Kang, Mei, Tong, Yin, Wei, Zheng, Liu, Peng, Wan, Liping, Song, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943423/
https://www.ncbi.nlm.nih.gov/pubmed/32873913
http://dx.doi.org/10.1038/s41409-020-01047-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943423/
https://www.ncbi.nlm.nih.gov/pubmed/32873913
http://dx.doi.org/10.1038/s41409-020-01047-2

Ejemplares similares